Fair Balance Prescription Drug Advertisement Act of 2000

To amend the Internal Revenue Code of 1986 to deny any deduction for direct-to-consumer advertisements of prescription drugs that fail to provide certain information or to present information in a balanced manner, and to amend the Federal Food, Drug, and Cosmetic Act to require reports regarding such advertisements.

Subjects

Taxation

Summary

Fair Balance Prescription Drug Advertisement Act of 2000 - Amends the Internal Revenue Code and the Federal Food, Drug, and Cosmetic Act (FDCA) to prohibit a deduction for any expense of an advertisement for a prescription drug if, with respect to such advertisement, the Secretary of Health and Human Services has submitted to the Secretary of the Treasury a report with respect to direct-to-consumer advertising that certain FDCA misbranding violations have occurred.

Full Text

Legislative Actions

2000-06-15
Introduced in House
2000-06-15
Introduced in House
2000-06-15
Sponsor introductory remarks on measure. (CR E1026-1028)
2000-06-15
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2000-06-15
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2000-06-15
Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2000-06-27
Referred to the Subcommittee on Health and Environment.

Ask about this bill

checking server…

Ask anything about this bill. The AI reads the full text to answer.